This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ASM journals
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Janulionis, E.
Right arrow Articles by Wallis, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Janulionis, E.
Right arrow Articles by Wallis, R. S.

 Previous Article  |  Next Article 

Infection and Immunity, May 2005, p. 2595-2601, Vol. 73, No. 5
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.5.2595-2601.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Survival and Replication of Clinical Mycobacterium tuberculosis Isolates in the Context of Human Innate Immunity

Ernestas Janulionis,1 Carolina Sofer,1 Stephan K. Schwander,1 Denarra Nevels,1 Barry Kreiswirth,2 Elena Shashkina,2 and Robert S. Wallis1*

UMDNJ-New Jersey Medical School,1 Public Health Research Institute, Newark, New Jersey2

Received 28 July 2004/ Returned for modification 16 September 2004/ Accepted 30 December 2004

The initial host response to Mycobacterium tuberculosis is driven by innate immunity. For this study, we examined the ability of 18 recent clinical isolates and 5 reference strains to survive and replicate in the context of host innate immunity by using whole blood culture. Six healthy tuberculin-negative volunteers served as subjects. H37Ra showed the least capacity to replicate of any of the strains tested, decreasing in viability 1.3 log CFU during 72 h of whole blood culture, whereas H37Rv increased 0.32 log. Clinical isolates varied greatly in their ability to replicate in blood cells, ranging from –0.4 to +0.8 log (P < 0.001). Four showed significantly more growth than H37Rv, and one showed significantly reduced growth. Host mechanisms for restricting intracellular mycobacterial growth were more effective during the first 24 h of whole blood culture than during the 24- to 72-h period. Certain mycobacterial isolates appeared preferentially able to withstand host defenses during each of these intervals. Although there was relatively more homogeneity among subjects than among strains, one of the six subjects showed a reduced capacity to restrict intracellular mycobacterial growth due to a defect expressed during the first 24 h of culture. Our findings indicate substantial variability in the capacity of clinical tuberculosis isolates to replicate in host cells in the face of innate host immunity.

* Corresponding author. Present address: PPD, 1213 N Street NW, Apt. A, Washington, DC 20005. Phone: (202) 360-4784. Fax: (919) 654-0640. E-mail: robert.wallis{at}columbia.ppdi.com.

Editor: F. C. Fang

Infection and Immunity, May 2005, p. 2595-2601, Vol. 73, No. 5
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.5.2595-2601.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Nardell, E. A., Wallis, R. S. (2006). Here today--gone tomorrow: the case for transient acute tuberculosis infection.. Am. J. Respir. Crit. Care Med. 174: 734-735 [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»